{
  "zip": "V6X 2W8",
  "sector": "Healthcare",
  "longBusinessSummary": "Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment. The company has a collaboration with the University of Maryland School of Medicine related to the discovery and validation of BioMark's assays for early lung cancer and monitoring of residual tumor load/activity. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.",
  "city": "Richmond",
  "phone": "604 370 0779",
  "state": "BC",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.biomarkdiagnostics.com",
  "maxAge": 1,
  "address1": "165â10551 Shellbridge Way",
  "industry": "Diagnostics & Research",
  "previousClose": 0.13769,
  "regularMarketOpen": 0.13769,
  "twoHundredDayAverage": 0.13316573,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.13769,
  "navPrice": null,
  "averageDailyVolume10Day": 12,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.13769,
  "fiftyDayAverage": 0.10951485,
  "trailingAnnualDividendRate": null,
  "open": 0.13769,
  "averageVolume10days": 12,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 2.109805,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.13769,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 100,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 9745960,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 5727,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.13769,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 100,
  "fiftyTwoWeekHigh": 0.2035,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0824,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.13769,
  "exchange": "PNK",
  "shortName": "BIOMARK DIAGNOSTICS INC",
  "longName": "Biomark Diagnostics Inc",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "BMKDF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_276547538",
  "uuid": "1bcaf995-b74e-34c9-85a3-6e2b18ec31d6",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 72863696,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1585612800,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.59580004,
  "nextFiscalYearEnd": 1648684800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 25941673,
  "enterpriseValue": 10032607,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.13769,
  "logo_url": "https://logo.clearbit.com/biomarkdiagnostics.com"
}